A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana ...

The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions.

Cancer Treatment 101: A Primer for Non-Oncologists Many of your patients are undergoing complicated, multiphase cancer treatments. We all need a basic understanding of what they are facing.

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...